Chronic inflammatory condition caused by hormone-dependent growth of endometrial-like tissue outside the uterus. Deposits may be superficial or infiltrating.
demographics: Women of reproductive age
Aetiology: not fully understood ?retrograde menstruation
- Other contributing factors include:
- Coelomic metaplasia → The coelomic (peritoneum) contains pluripotent cells that differentiated into endometrial cells during embryonic development.
- Iatrogenic implantation → Postsurgical scars through episiotomy or laparotomy are thought to be prime locations for implantation of endometrial cells that are spread from delivery or surgical procedures.
- Hematogenic and lymphogenic dissemination of endometrial cells
- Hereditary component
Pathophysiology
- viable cells from retrograde menstruation → peritoneal fluid → implant, grow, and infiltrate in the peritoneal cavity
- Regardless of location, remains sensitive to oestrogen so clinical features depend on menstrual cycle
- repeated inflammation and scarring → adhesions
- Common locations of endometriotic implants include:
- Pelvic organs
- Ovaries: most common site; often affected bilaterally
- Rectouterine pouch
- Fallopian tubes
- Bladder
- Cervix
- Peritoneum
- Extrapelvic organs (e.g., lung or diaphragm): less commonly affected
Risk factors
- Nulliparity
- Prolonged exposure to endogenous estrogen (early menarche, late menopause)
- Short menstrual cycles (< 27 days)
- Menorrhagia (> 1 week)
- Family history- Individuals with an affected first-degree relative have a three- to ten-fold increased risk of endometriosis.
- greater height
- defects in uterus or fallopian tubes